3SORBERA L A, CASTANER J, SILVESTRE J S.Erlotinib hydrochloride, oncolytic EGF receptor inhibitor[J]. Drugs Future,2002 ,27 (10) :923 - 934.
4SCHNUR R C, ARNOLD L D. Alkynyl and azid-osubstituted 4-anilinoquinazolines: US, 5747498 [P]. 1998 -05 -05.
5SCHNUR R C, ARNOLD L D. Quinazoline derivatives: WO, 1996030347 [P]. 1996 -10 - 03.
6KNESL P, ROSELING D, JORDIS U. Improved synthesis of substituted 6, 7 -dihydroxy-4-quinazolineamines , tandutinib, erlotinib and gefitinib [J]. Molecules ,2006,11 (4) :286 - 297.
7RAMANADHAM J P, BOLLEP ALLI N R, NANNAP ANENI V C. A novel process for the preparation of erlotinib, WO,200706069l [P]' 2007 -05 - 31.
8CHANDREGOWDA V, RAO G V, REDDY G C. One-pot conversion of 2-nitrobenzonitriles to quinazolin-4 ( 3H) -ones and synthesis of gefitinib and erlotinib hydrochloride [J]. Heterocycles, 2007 , 71 (1) :39 -48.
9VENKATESHAPPA C, VENKATESW ARA R G, KUNAR K A. A process for synthesis of [6 , 7 -bis(2-methoxyethoxy) -quinazolin] -4-yl] -quinazolin-4- yl] -( 3-ethynylphenyl) amine hydrochloride: WO, 2007138613 [P]. 2007 -12 - 06.
